Patents by Inventor Scott Marr

Scott Marr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED SESQUITERPENE SYNTHASES
    Publication number: 20250027070
    Abstract: Provided in this disclosure are engineered sesquiterpene synthases, host cells expressing engineered sesquiterpene synthases and methods for making alpha-guaiene.
    Type: Application
    Filed: November 18, 2022
    Publication date: January 23, 2025
    Applicant: Ginkgo Bioworks, Inc.
    Inventors: Jeffrey Ian Boucher, Dylan Alexander Carlin, Cinzia Formighieri, Bryan Greenhagen, Jaide Jensen, Scott Marr
  • Chimeric terpene synthases
    Patent number: 12077799
    Abstract: Described herein are chimeric terpene synthases, methods for making chimeric terpene synthases, and methods for making terpenes using the same.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: September 3, 2024
    Assignee: Ginkgo Bioworks, Inc.
    Inventors: Christian Ridley, Jue Wang, Scott Marr
  • PRODUCTION OF VACCINIA CAPPING ENZYME
    Publication number: 20240182877
    Abstract: Aspects of the disclosure relate to production of vaccinia capping enzyme (VCE) in host cells. For example, host cells may comprise: a promoter; a ribosome binding site (RBS); a nucleic acid encoding a vaccinia capping enzyme (VCE) or VCE subunit; and a terminator.
    Type: Application
    Filed: March 29, 2022
    Publication date: June 6, 2024
    Applicant: Ginkgo Bioworks, Inc.
    Inventors: Josef Bober, Jeffrey Ian Boucher, Justin Michael Gardin, Jason King, Scott Marr, Matthew McMahon, Krishnaben S. Patel, Abraham Waldman
  • BIOSYNTHESIS OF MOGROSIDES
    Publication number: 20230174993
    Abstract: Described in this application are UDP-glycosyltransferases (UGT) enzymes, host cells expressing the UGTs, and methods of producing mogrol precursors, mogrol, and/or mogrosides using such host cells.
    Type: Application
    Filed: May 13, 2021
    Publication date: June 8, 2023
    Applicant: Ginkgo Bioworks, Inc.
    Inventors: Jeffrey Ian Boucher, Justin Michael Gardin, Scott Marr, Matthew McMahon, Krishnaben S. Patel, Jie Zhu
  • BIOSYNTHESIS OF MOGROSIDES
    Publication number: 20220378072
    Abstract: The disclosure relates to enzymes, such as cucurbitadienol synthase (CDS), UDP-glycosyltransferase (UGT), C11 hydroxylase, epoxide hydrolase (EPH), squalene epoxidase (SQE), and/or cytochrome P450 reductase enzymes, recombinant host cells expressing the enzymes, and methods of producing mogrol precursors, mogrol, and/or mogrosides using such recombinant cells.
    Type: Application
    Filed: October 23, 2020
    Publication date: December 1, 2022
    Applicant: Ginkgo Bioworks, Inc.
    Inventors: Jeffrey Ian Boucher, Matthew McMahon, Scott Marr, Jie Zhu
  • BIOSYNTHESIS OF MOGROSIDES
    Publication number: 20210403921
    Abstract: Described in this application are enzymes (e.g., cucurbitadienol synthases (CDS), UDP-glycosyltransferases (UGT), C11 hydroxylases, epoxide hydrolases (EPH), squalene epoxidases, and/or cytochrome P450 reductases), host cells expressing the enzymes, and methods of producing mogrol precursors, mogrol, and/or mogrosides using such host cells.
    Type: Application
    Filed: November 9, 2019
    Publication date: December 30, 2021
    Applicant: Ginkgo Bioworks, Inc.
    Inventors: Kim Cecelia Anderson, Jeffrey Ian Boucher, Nicholas Flores, Jaide Jensen, Scott Marr, Matthew McMahon, Dayal Saran, Jue Wang, Jie Zhu
  • CHIMERIC TERPENE SYNTHASES
    Publication number: 20210147880
    Abstract: Described herein are chimeric terpene synthases, methods for making chimeric terpene synthases, and methods for making terpenes using the same.
    Type: Application
    Filed: February 14, 2019
    Publication date: May 20, 2021
    Applicant: Ginkgo Bioworks, Inc.
    Inventors: Christian Ridley, Jue Wang, Scott Marr